Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Beckman Coulter Genomics Partners With Genpathway

By R&D Editors | March 18, 2010

Beckman Coulter Genomics Inc. and Genpathway, Inc., announced a strategic partnership to offer customers whole-genome chromatin immunoprecipitation sequencing (ChIP-Seq) services. The alliance provides researchers investigating gene regulation and genetic pathways a single, inclusive source for services supporting genome-wide studies of transcription factor binding, gene transcription and epigenetic events.

“Partnering with leading-edge innovators to respond to the dynamic research needs of scientists worldwide is fundamental to our goals as an essential genomic services provider,” said Elizabeth Nickerson, global business line leader of DNA sequencing services at Beckman Coulter Genomics. “This alliance with Genpathway strategically leverages both companies’ core competencies and expertise to supplement our DNA sequencing services with the highest-quality, most reliable ChIP-Seq capabilities available.”

ChIP-Seq combines the sophistication of chromatin immunoprecipitation with the power of ultra high-throughput next generation DNA sequencing to enable the study of complex interactions between proteins and nucleic acids. Mapping protein-DNA complexes in vivo on a genome-wide scale with ChIP-Seq builds a picture of the intricate network of interactions that regulate genes and genetic pathways in a sample. Comparing ChIP-Seq results from different conditions – diseased versus normal cells, for example – can reveal distinguishing patterns of genetic regulation that may be biologically significant.

“We are pleased that Beckman Coulter Genomics has selected Genpathway as its partner to accommodate the unprecedented requirement for ChIP-based technologies to advance studies of biological processes and disease states,” said Patrick Mallon, CEO of Genpathway. “This dynamic new alliance is a natural fit, coupling Beckman Coulter Genomics’ sequencing and marketing capabilities with Genpathway’s ChIP experience to offer the global research community an expert source of ChIP sequencing data and analysis.”

Beckman Coulter Genomics services include Sanger and next generation DNA sequencing, gene expression profiling, genotyping and biologics testing. The collaboration with Genpathway further expands the company’s extensive DNA sequencing applications portfolio, which is available to clients worldwide. The start-to-finish ChIP-Seq services will include ChIP experimental design and consultation, antibody qualification, performance of ChIP assays with post-ChIP QC, next generation sequencing and comprehensive data analysis.

Date: February 2, 2010
Source: Beckman Coulter Genomics

Related Articles Read More >

2025 R&D layoffs tracker tops 92,000
Health-related innovation in Morocco highlighted by resident inventor patenting activity
ARPA-H funds $29M Ginkgo-led project to reshore pharma supply chains using wheat germ tech
DNA microscope offers new 3D view of organisms from the inside out
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE